Repligen Corp Asset Turnover Ratio (RGEN), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Repligen Corp  (NASDAQ: RGEN)
 

Repligen Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Repligen Corp asset turnover ratio, the ability of Repligen Corp's assets to generate revenue in the second quarter 2026, increased sequentially to 0.27 in the second quarter (Jun 30 2026), yet the ratio remained below the average, as RGEN's position remain challenging.

Within sector 37 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2026 compared to the preceding quarter from 1912 to 2597.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGEN Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 1.67 % 2.76 % 9.38 % 8.06 % 6.01 %
Y / Y Revenue Change 11.93 % 14.83 % 18.12 % 21.91 % 14.81 %
Asset Turnover Ratio (TTM) 0.27 0.26 0.25 0.25 0.24
RGEN's Total Ranking # 2597 # 1912 # 2454 # 2593 # 2520
Seq. Asset Change 0.66 % -0.64 % 0.89 % 0.76 % 1.73 %
Seq. Revenue Change 5.08 % -1.85 % 4.82 % 3.53 % 7.8 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 38
Healthcare Sector # 368
Overall Market # 2597

Asset Turnover Ratio Statistics
High Average Low
8.33 6.26 4.75
(Dec 31 2014)   (Jun 30 2025)




RGEN Company Profile • Back to RGEN Efficiency Comparisons • Compare RGEN Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Biomerica Inc   0.73 $ 4.453  Millions$ 6.109  Millions
Tenet Healthcare Corp  0.72 $ 21,812.000  Millions$ 30,243.500  Millions
Neurocrine Biosciences Inc   0.70 $ 3,373.900  Millions$ 4,790.625  Millions
Establishment Labs Holdings Inc   0.70 $ 245.105  Millions$ 349.756  Millions
Quest Diagnostics Inc  0.70 $ 11,560.000  Millions$ 16,508.500  Millions
Jaguar Health Inc   0.70 $ 27.815  Millions$ 39.856  Millions
Pulmonx Corporation  0.70 $ 87.393  Millions$ 125.568  Millions
Gyre Therapeutics Inc   0.70 $ 119.383  Millions$ 171.697  Millions
3m Company  0.69 $ 25,180.000  Millions$ 36,426.000  Millions
Illumina Inc   0.69 $ 4,493.000  Millions$ 6,507.500  Millions
Neuraxis Inc   0.69 $ 5.316  Millions$ 7.731  Millions
Harrow Inc   0.69 $ 274.724  Millions$ 399.729  Millions
Ani Pharmaceuticals Inc  0.68 $ 978.379  Millions$ 1,441.153  Millions
Immucell Corporation  0.67 $ 29.777  Millions$ 44.750  Millions
Guardant Health Inc   0.66 $ 1,183.105  Millions$ 1,779.508  Millions
U S Physical Therapy Inc  0.66 $ 812.203  Millions$ 1,222.803  Millions
Resmed Inc   0.66 $ 5,628.170  Millions$ 8,558.245  Millions
Anika Therapeutics Inc   0.65 $ 121.370  Millions$ 185.642  Millions
Agenus Inc  0.65 $ 132.693  Millions$ 204.959  Millions
Logicmark Inc  0.64 $ 12.544  Millions$ 19.555  Millions
Strata Critical Medical Inc   0.64 $ 211.642  Millions$ 330.217  Millions
Bridgebio Pharma Inc   0.63 $ 713.069  Millions$ 1,130.639  Millions
Ss Innovations International Inc  0.63 $ 52.199  Millions$ 82.833  Millions
Rigel Pharmaceuticals Inc  0.62 $ 276.785  Millions$ 445.451  Millions
Bioaffinity Technologies Inc   0.62 $ 5.901  Millions$ 9.518  Millions
Macrogenics Inc   0.61 $ 167.674  Millions$ 272.723  Millions
Heron Therapeutics Inc   0.60 $ 151.507  Millions$ 250.826  Millions
10x Genomics Inc   0.60 $ 616.566  Millions$ 1,028.638  Millions
Heartflow Inc   0.60 $ 210.791  Millions$ 353.085  Millions
Pacira Biosciences inc   0.60 $ 746.164  Millions$ 1,253.752  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.